Terms: = Breast cancer AND CD79B, ENSG00000007312, 974, P40259, IGB, B29 AND Treatment
60 results:
1. Retrospective case-control study examining the relationship between recurrence-free survival and changes in pre- and post-radioiodine therapy serum thyroglobulin levels in patients with differentiated thyroid cancer.
Watanabe K; Igarashi T; Uchiyama M; Ishigaki T; Ojiri H
Jpn J Radiol; 2024 Apr; 42(4):391-397. PubMed ID: 38212512
[TBL] [Abstract] [Full Text] [Related]
2. Primary breast diffuse large B-cell lymphoma in the rituximab era: A retrospective study of the Chinese Southwest Oncology Group.
Weng H; Shrestha PR; Hong H; Chen Z; Yu L; Yao Y; Zhang Z; Zou L; Zhu B; Zhou H; Liu X; Liu Y; Guo H; Huang H; Lin T
Cancer Med; 2023 Dec; 12(23):21188-21198. PubMed ID: 37997571
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of the effects of high-intensity interval and moderate-intensity continuous training on inflammatory markers, cardiorespiratory fitness, and quality of life in breast cancer patients.
Isanejad A; Nazari S; Gharib B; Motlagh AG
J Sport Health Sci; 2023 Nov; 12(6):674-689. PubMed ID: 37423313
[TBL] [Abstract] [Full Text] [Related]
4. An MRI-Based Radiomics Nomogram to Distinguish Ductal Carcinoma In Situ with Microinvasion From Ductal Carcinoma In Situ of breast cancer.
Wu Z; Lin Q; Wang H; Wang G; Fu G; Bian T
Acad Radiol; 2023 Sep; 30 Suppl 2():S71-S81. PubMed ID: 37211478
[TBL] [Abstract] [Full Text] [Related]
5. Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study.
Medas F; Dobrinja C; Al-Suhaimi EA; Altmeier J; Anajar S; Arikan AE; Azaryan I; Bains L; Basili G; Bolukbasi H; Bononi M; Borumandi F; Bozan MB; Brenta G; Brunaud L; Brunner M; Buemi A; Canu GL; Cappellacci F; Cartwright SB; Castells Fusté I; Cavalheiro B; Cavallaro G; Chala A; Chan SYB; Chaplin J; Cheema MS; Chiapponi C; Chiofalo MG; Chrysos E; D'Amore A; de Cillia M; De Crea C; de Manzini N; de Matos LL; De Pasquale L; Del Rio P; Demarchi MS; Dhiwakar M; Donatini G; Dora JM; D'Orazi V; Doulatram Gamgaram VK; Eismontas V; Kabiri EH; El Malki HO; Elzahaby I; Enciu O; Eskander A; Feroci F; Figueroa-Bohorquez D; Filis D; François G; Frías-Fernández P; Gamboa-Dominguez A; Genc V; Giordano D; Gómez-Pedraza A; Graceffa G; Griffin J; Guerreiro SC; Gupta K; Gupta KK; Gurrado A; Hajiioannou J; Hakala T; Harahap WA; Hargitai L; Hartl D; Hellmann A; Hlozek J; Hoang VT; Iacobone M; Innaro N; Ioannidis O; Jang JHI; Xavier-Junior JC; Jovanovic M; Kaderli RM; Kakamad F; Kaliszewski K; Karamanliev M; Katoh H; Košec A; Kovacevic B; Kowalski LP; Králik R; Yadav SK; Kumorová A; Lampridis S; Lasithiotakis K; Leclere JC; Leong EKF; Leow MK; Lim JY; Lino-Silva LS; Liu SYW; Llorach NP; Lombardi CP; López-Gómez J; Lori E; Quintanilla-Dieck L; Lucchini R; Madani A; Manatakis D; Markovic I; Materazzi G; Mazeh H; Mercante G; Meyer-Rochow GY; Mihaljevic O; Miller JA; Minuto M; Monacelli M; Mulita F; Mullineris B; Muñoz-de-Nova JL; Muradás Girardi F; Nader S; Napadon T; Nastos C; Offi C; Ronen O; Oragano L; Orois A; Pan Y; Panagiotidis E; Panchangam RB; Papavramidis T; Parida PK; Paspala A; Pérez ÒV; Petrovic S; Raffaelli M; Ramacciotti CF; Ratia Gimenez T; Rivo Vázquez Á; Roh JL; Rossi L; Sanabria A; Santeerapharp A; Semenov A; Seneviratne S; Serdar A; Sheahan P; Sheppard SC; Slotcavage RL; Smaxwil C; Kim SY; Sorrenti S; Spartalis E; Sriphrapradang C; Testini M; Turk Y; Tzikos G; Vabalayte K; Vargas-Osorio K; Vázquez Rentería RS; Velázquez-Fernández D; Vithana SMP; Yücel L; Yulian ED; Zahradnikova P; Zarogoulidis P; Ziablitskaia E; Zolotoukho A; Calò PG;
Lancet Diabetes Endocrinol; 2023 Jun; 11(6):402-413. PubMed ID: 37127041
[TBL] [Abstract] [Full Text] [Related]
6. Safety and tolerability of subcutaneous trastuzumab and intravenous pertuzumab as adjuvant treatment for HER2 positive breast cancer: a pilot study.
Wong CY; Leung R; Kwok GW; Tsang J; Li B; Yau T; Chiu J
Postgrad Med J; 2022 Sep; 98(1163):666-669. PubMed ID: 37062975
[TBL] [Abstract] [Full Text] [Related]
7. New insights into breast microcalcification for poor prognosis: NACT cohort and bone metastasis evaluation cohort.
Hu Y; Mao L; Wang M; Li Z; Li M; Wang C; Ji L; Zeng H; Zhang X
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7285-7297. PubMed ID: 36917189
[TBL] [Abstract] [Full Text] [Related]
8. Impact of Medicaid Expansion on breast cancer Diagnosis and treatment in Southern States.
Laughlin AI; Li T; Yu Q; Wu XC; Yi Y; Hsieh MC; Havron W; Shoup M; Chu QD
J Am Coll Surg; 2023 Apr; 236(4):838-845. PubMed ID: 36722711
[TBL] [Abstract] [Full Text] [Related]
9. Association between human blood metabolome and the risk of breast cancer.
Wang Y; Liu F; Sun L; Jia Y; Yang P; Guo D; Shi M; Wang A; Chen GC; Zhang Y; Zhu Z
Breast Cancer Res; 2023 Jan; 25(1):9. PubMed ID: 36694207
[TBL] [Abstract] [Full Text] [Related]
10. Machine learning with textural analysis of longitudinal multiparametric MRI and molecular subtypes accurately predicts pathologic complete response in patients with invasive breast cancer.
Syed A; Adam R; Ren T; Lu J; Maldjian T; Duong TQ
PLoS One; 2023; 18(1):e0280320. PubMed ID: 36649274
[TBL] [Abstract] [Full Text] [Related]
11. Machine learning predicts the prognosis of breast cancer patients with initial bone metastases.
Li C; Liu M; Li J; Wang W; Feng C; Cai Y; Wu F; Zhao X; Du C; Zhang Y; Wang Y; Zhang S; Qu J
Front Public Health; 2022; 10():1003976. PubMed ID: 36225783
[TBL] [Abstract] [Full Text] [Related]
12. Development of an automated liquid biopsy assay for methylated markers in advanced breast cancer.
Fackler MJ; Tulac S; Venkatesan N; Aslam AJ; de Guzman TN; Mercado-Rodriguez C; Cope LM; Downs BM; Vali AH; Ding W; Lehman J; Denbow R; Reynolds J; Buckley ME; Visvanathan K; Umbricht CB; Wolff AC; Stearns V; Bates M; Lai EW; Sukumar S
Cancer Res Commun; 2022 Jun; 2(6):391-401. PubMed ID: 36046124
[TBL] [Abstract] [Full Text] [Related]
13. Analysis of Rates of Brain Metastases and Association With breast cancer Subtypes in Ontario, Canada.
Wang XY; Rosen MN; Chehade R; Sahgal A; Das S; Warner E; Saskin R; Zhang B; Soliman H; Chan KKW; Jerzak KJ
JAMA Netw Open; 2022 Aug; 5(8):e2225424. PubMed ID: 35960523
[TBL] [Abstract] [Full Text] [Related]
14. The influence of metabolic factors and ethnicity on breast cancer risk, treatment and survival: The Oslo ethnic breast cancer study.
Lofterød T; Frydenberg H; Veierød MB; Jenum AK; Reitan JB; Wist EA; Thune I
Acta Oncol; 2022 May; 61(5):649-657. PubMed ID: 35348396
[TBL] [Abstract] [Full Text] [Related]
15. Short- and long-term recurrence of early-stage invasive ductal carcinoma in middle-aged and old women with different treatments.
Kao Y; Wu YJ; Hsu CC; Lin HJ; Wang JJ; Tian YF; Weng SF; Huang CC
Sci Rep; 2022 Mar; 12(1):4422. PubMed ID: 35292677
[TBL] [Abstract] [Full Text] [Related]
16. The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations.
Tomiczek-Szwiec J; Szwiec M; Falco M; Cybulski C; Wokolorczyk D; Jakubowska A; Gronwald J; Stawicka M; Godlewski D; Kilar E; Marczyk E; Siołek M; Wiśniowski R; Haus O; Sibilski R; Bodnar L; Sun P; Narod SA; Lubinski J; Huzarski T;
Br J Cancer; 2022 Jul; 127(1):84-91. PubMed ID: 35256754
[TBL] [Abstract] [Full Text] [Related]
17. Recent updates on Wnt signaling modulators: a patent review (2014-2020).
Goswami VG; Patel BD
Expert Opin Ther Pat; 2021 Nov; 31(11):1009-1043. PubMed ID: 34128760
[No Abstract] [Full Text] [Related]
18. Early Assessment Window for Predicting breast cancer Neoadjuvant Therapy using Biomarkers, Ultrasound, and Diffuse Optical Tomography.
Zhu Q; Ademuyiwa FO; Young C; Appleton C; Covington MF; Ma C; Sanati S; Hagemann IS; Mostafa A; Uddin KMS; Grigsby I; Frith AE; Hernandez-Aya LF; Poplack SS
Breast Cancer Res Treat; 2021 Aug; 188(3):615-630. PubMed ID: 33970392
[TBL] [Abstract] [Full Text] [Related]
19. Impact of Exercise on Chemotherapy Tolerance and Survival in Early-Stage breast cancer: A Nonrandomized Controlled Trial.
Kirkham AA; Gelmon KA; Van Patten CL; Bland KA; Wollmann H; McKenzie DC; Landry T; Campbell KL
J Natl Compr Canc Netw; 2020 Dec; 18(12):1670-1677. PubMed ID: 33285521
[TBL] [Abstract] [Full Text] [Related]
20. Health-related quality of life in breast cancer patients: review of reviews from 2008 to 2018.
Mokhtari-Hessari P; Montazeri A
Health Qual Life Outcomes; 2020 Oct; 18(1):338. PubMed ID: 33046106
[TBL] [Abstract] [Full Text] [Related]
[Next]
